Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model (Q45778750)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 1994

Language	Label	Description	Also known as
English	Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model	scientific article published in April 1994

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

M Sivanandham

1

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

S D Scoggin

2

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

N Tanaka

3

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

M K Wallack

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 1994

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

38

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

4

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

259-264

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

Presence on a human melanoma of multiple antigens recognized by autologous CTL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons and interferon inducers in cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of recombinant tumor necrosis factor in cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon therapy in cancer: from imaginon to interferon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific tumor immunity produced by the injection of vaccinia viral oncolysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functionally different HTLV I-infected T cell lines with the same phenotype derived from a patient with melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of recombinant interleukin 2 in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach in specific, active immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular mechanisms of tumor rejection in vivo and enhanced induction of anti tumor protective immunity applicable to tumor-specific immunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Southeastern Cancer Study Group phase I/II trial with vaccinia melanoma oncolysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of interferon-gamma on the activation of human T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccinia virus-infected C-C36 colon tumor cell lysates stimulate cellular responses in vitro and protect syngeneic Balb/c mice from tumor cell challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative morphological study of the mammary gland in a high and a low tumor strain of mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a human homologue of the murine tumor rejection antigen GP96

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of murine hepatic metastases with vaccinia colon oncolysates and IL-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel approach to the generation and identification of experimental hepatic metastases in a murine model

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trials with VMO for melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serologic response to human melanoma lines from patients with melanoma undergoing treatment with vaccinia melanoma oncolysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in cellular immunology: implications for immunity to cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal expansion of T cells following in vitro stimulation with autologous melanoma cells and interleukin-2 studied by molecular analysis of a T cell receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell clones that react against autologous human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2: inception, impact, and implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons: biological and clinical effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal analysis of the cytolytic T-cell response to human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8168121

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S002620050062

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 December 2017

http://europepmc.org/abstract/MED/8168121

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45778750&oldid=2082295649"